People of color in North America report improvements in racial trauma and mental health symptoms following psychedelic experiences

Monnica T Williams, Alan K Davis, Yitong Xin, Nathan D Sepeda, Pamela Colόn Grigas, Sinead Sinnott, Angela M Haeny, Monnica T Williams, Alan K Davis, Yitong Xin, Nathan D Sepeda, Pamela Colόn Grigas, Sinead Sinnott, Angela M Haeny

Abstract

This study examined how psychedelics reduced symptoms of racial trauma among black, indigenous, and people of color (BIPOC) subsequent to an experience of racism. A cross-sectional internet-based survey included questions about experiences with racism, mental health symptoms, and acute and enduring psychedelic effects. Changes in mental health were assessed by retrospective report of symptoms in the 30 days before and 30 days after an experience with psilocybin, Lysergic acid diethylamide (LSD), or 3,4-Methylenedioxymethamphetamine (MDMA). We recruited 313 diverse BIPOC in the US and Canada. Results revealed a significant (p < .001) and moderate (d = -.45) reduction in traumatic stress symptoms from before-to-after the psychedelic experience. Similarly, participants reported decreases in depression (p < .001; d = -.52), anxiety (p < .001; d = -.53), and stress (p < .001; d = -.32). There was also a significant relationship (Rc = 0.52, p < .001) between the dimension of acute psychedelic effects (mystical-type, insight, and challenging experiences) and decreases in a cluster of subsequent psychopathology (traumatic stress, depression, anxiety, and stress), while controlling for the frequency of prior discrimination and the time since the psychedelic experience. BIPOC have been underrepresented in psychedelic studies. Psychedelics may decrease the negative impact of racial trauma. Future studies should examine the efficacy of psychedelic-assisted therapy for individuals with a history of race-based trauma.

Keywords: Psychedelics; ethnic minorities; hallucinogens; people of color; racial trauma; substance use.

Figures

Figure 1.
Figure 1.
Canonical Correlation Analysis (N=313), F20,1009 = 5.571, p < .001; correlation =.52. Variance explained: Set 1 (acute effects): .29; Set 2 (MH variables): .68. Control variables: Time since psychedelic experience occurred and frequency of ethnic discrimination prior to psychedelic experience. ***p<.001.

References

    1. Aixalá M, Ona G, Parés Ò., & Bouso JC (2020). Patterns of use, desired effects, and mental health status of a sample of natural psychoactive drug users. Drugs: Education, Prevention and Policy, 27(3), 191–198. 10.1080/09687637.2019.1611739
    1. Amoroso T, & Workman M (2016). Treating posttraumatic stress disorder with MDMA-assisted psychotherapy: A preliminary meta-analysis and comparison to prolonged exposure therapy. Journal of Psychopharmacology (Oxford, England), 30(7), 595–600. 10.1177/0269881116642542
    1. APA. (2013). Diagnostic and statistical manual of mental disorders (5th ed.). American Psychiatric Publishing.
    1. Apfelbaum EP, Sommers SR, & Norton MI (2008). Seeing race and seeming racist? Evaluating strategic colorblindness in social interaction. Journal of Personality and Social Psychology, 95(4), 918–932. 10.1037/a0011990
    1. Argento E, Braschel M, Walsh Z, Socias ME, & Shannon K (2018). The moderating effect of psychedelics on the prospective relationship between prescription opioid use and suicide risk among marginalized women. Journal of Psychopharmacology (Oxford, England), 32(12), 1385–1391. 10.1177/0269881118798610
    1. Asmundson GJG, Thorisdottir AS, Roden-Foreman JW, Baird SO, Witcraft SM, Stein AT, Smits JAJ, & Powers MB (2019). A meta-analytic review of cognitive processing therapy for adults with posttraumatic stress disorder. Cognitive Behaviour Therapy, 48(1), 1–14. 10.1080/16506073.2018.1522371
    1. Atkins R (2015). Depression in black single mothers: A test of a theoretical model. Western Journal of Nursing Research, 37(6), 812–830. 10.1177/0193945914528289
    1. Barrett FS, Bradstreet MP, Leoutsakos J-MS, Johnson MW, & Griffiths RR (2016). The challenging experience questionnaire: Characterization of challenging experiences with psilocybin mushrooms. Journal of Psychopharmacology (Oxford, England), 30(12), 1279–1295. 10.1177/0269881116678781
    1. Barrett FS, Doss MK, Sepeda ND, Pekar JJ, & Griffiths RR (2020). Emotions and brain function are altered up to one month after a single high dose of psilocybin. Scientific Reports, 10(1), 2214. 10.1038/s41598-020-59282-y
    1. Barrett FS, Johnson MW, & Griffiths RR (2015). Validation of the revised Mystical Experience Questionnaire in experimental sessions with psilocybin. Journal of Psychopharmacology, 29(11), 1182–1190. 10.1177/0269881115609019
    1. Bor J, Venkataramani AS, Williams DR, & Tsai AC (2018). Police killings and their spillover effects on the mental health of black Americans: A population-based, quasi-experimental study. The Lancet, 392(10144), 302–310. (18)31130–9. 10.1016/S0140-6736(18)31130-9
    1. Bryant-Davis T, & Ocampo C (2006). A therapeutic approach to the treatment of racist-incident-based trauma. Journal of Emotional Abuse, 6(4), 1–22. 10.1300/J135v06n04_01
    1. Budhwani H, Hearld KR, & Chavez-Yenter D (2015). Depression in racial and ethnic minorities: The impact of nativity and discrimination. Journal of Racial and Ethnic Health Disparities, 2(1), 34–42. 10.1007/s40615-014-0045-z
    1. Butts HF (2002). The black mask of humanity: Racial/ethnic discrimination and post-traumatic stress disorder. The Journal of the American Academy of Psychiatry and the Law, 30(3), 336–339.
    1. Carhart-Harris RL, Bolstridge M, Rucker J, Day CMJ, Erritzoe D, Kaelen M, Bloomfield M, Rickard JA, Forbes B, Feilding A, Taylor D, Pilling S, Curran VH, & Nutt DJ (2016). Psilocybin with psychological support for treatment-resistant depression: An open-label feasibility study. The Lancet Psychiatry, 3(7), 619–627. 10.1016/S2215-0366(16)30065–7
    1. Carter RT (2007). Racism and psychological and emotional injury: Recognizing and assessing race-based traumatic stress. The Counseling Psychologist, 35(1), 13–105. 10.1177/0011000006292033
    1. Chandler J, Mueller P, & Paolacci G (2014). Nonnaïveté among Amazon Mechanical Turk workers: Consequences and solutions for behavioral researchers. Behavior Research Methods, 46(1), 112–130. 10.3758/s13428-013-0365-7
    1. Clark TT, Salas-Wright CP, Vaughn MG, & Whitfield KE (2015). Everyday discrimination and mood and substance use disorders: A latent profile analysis with African Americans and Caribbean Blacks. Addictive Behaviors, 40, 119–125. 10.1016/j.addbeh.2014.08.006
    1. Cloitre M (2009). Effective psychotherapies for posttraumatic stress disorder: A review and critique. CNS Spectrums, 14(1 Suppl 1), 32–43.
    1. Cox K, Lancelotta RL, Barsuglia J, & Davis AK (2018). November). 5-MeO-DMT and subjective improvements in post-traumatic stress disorder [Poster presentation]. Annual Convention of the Maryland Psychological Association.
    1. Dattalo PV (2014). A demonstration of canonical correlation analysis with orthogonal rotation to facilitate interpretation [Unpublished manuscript]. School of Social Work, Virginia Commonwealth University, Richmond, Virginia.
    1. Davis AK, Barrett FS, So S, Gukasyan N, Swift TC, & Griffiths RR (In press). Development of the Psychological Insight Questionnaire among a sample of people who have consumed psilocybin or LSD. Journal of Psychopharmacology.
    1. Davis AK, Barrett FS, & Griffiths RR (2020). Psychological flexibility mediates the relations between acute psychedelic effects and subjective decreases in depression and anxiety. Journal of Contextual Behavioral Science, 15, 39–45. 10.1016/j.jcbs.2019.11.004
    1. Davis AK, Barrett FS, May DG, et al. Effects of Psilocybin-Assisted Therapy on Major Depressive Disorder: A Randomized Clinical Trial. JAMA Psychiatry. Published online November 04, 2020. doi:10.1001/jamapsy-chiatry.2020.3285
    1. Davis AK, So S, Lancelotta R, Barsuglia JP, & Griffiths RR (2019). 5-methoxy-N,N-dimethyltryptamine (5-MeO-DMT) used in a naturalistic group setting is associated with unintended improvements in depression and anxiety. The American Journal of Drug and Alcohol Abuse, 45(2), 161–169. 10.1080/00952990.2018.1545024
    1. Department of Justice. (2014). Hate crime statistics. Department of Justice. Retrieved June 2, 2020, from
    1. Desalu JM, Goodhines PA, & Park A (2019). Racial discrimination and alcohol use and negative drinking consequences among Black Americans: A meta-analytical review. Addiction (Abingdon, England), 114(6), 957–967. 10.1111/add.14578
    1. Foa EB, Rothbaum BO, Riggs DS, & Murdock TB (1991). Treatment of posttraumatic stress disorder in rape victims: A comparison between cognitive-behavioral procedures and counseling. Journal of Consulting and Clinical Psychology, 59(5), 715–723. 10.1037//0022-006X.59.5.715
    1. Gerrard M, Gibbons FX, Fleischli ME, Cutrona CE, & Stock ML (2018). Moderation of the effects of discrimination-induced affective responses on health outcomes. Psychology & Health, 33(2), 193–212. 10.1080/08870446.2017.1314479
    1. Gerrard M, Stock ML, Roberts ME, Gibbons FX, O’Hara RE, Weng C, & Wills TA (2012). Coping with racial discrimination: The role of substance use. Psychology of Addictive Behaviors: Journal of the Society of Psychologists in Addictive Behaviors, 26(3), 550–560. 10.1037/a0027711
    1. Godley J (2018). Everyday discrimination in Canada: Prevalence and patterns. Canadian Journal of Sociology, 43(2), 111–142. 10.29173/cjs29346
    1. Gone JP, Hartmann WE, Pomerville A, Wendt DC, Klem SH, & Burrage RL (2019). The impact of historical trauma on health outcomes for indigenous populations in the USA and Canada: A systematic review. The American Psychologist, 74(1), 20–35. 10.1037/amp0000338
    1. Griffiths RR, Hurwitz ES, Davis AK, Johnson MW, & Jess R (2019). Survey of subjective “God encounter experiences”: Comparisons among naturally occurring experiences and those occasioned by the classic psychedelics psilocybin, LSD, ayahuasca, or DMT. PloS One, 14(4), e0214377. 10.1371/journal.pone.0214377
    1. Griffiths RR, Johnson MW, Carducci MA, Umbricht A, Richards WA, Richards BD, Cosimano MP, & Klinedinst MA (2016). Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial. Journal of Psychopharmacology, 30(12), 1181–1197. 10.1177/0269881116675513
    1. Griffiths RR, Johnson MW, Richards WA, Richards BD, McCann U, & Jesse R (2011). Psilocybin occasioned mystical-type experiences: Immediate and persisting dose-related effects. Psychopharmacology, 218(4), 649–665. 10.1007/s00213-011-2358-5
    1. Hurd NM, Varner FA, Caldwell CH, & Zimmerman MA (2014). Does perceived racial discrimination predict changes in psychological distress and substance use over time? An examination among Black emerging adults. Developmental Psychology, 50(7), 1910–1918. 10.1037/a0036438
    1. Huynh VW (2012). Ethnic microaggressions and the depressive and somatic symptoms of Latino and Asian American adolescents. Journal of Youth and Adolescence, 41(7), 831–846. 10.1007/s10964-012-9756-9
    1. IBM Corp. (2020). IBM SPSS Statistics for Windows (Version 27.0) [Computer software]. IBM Corp.
    1. Johansen P-Ø, & Krebs TS (2015). Psychedelics not linked to mental health problems or suicidal behavior: A population study. Journal of Psychopharmacology (Oxford, England), 29(3), 270–279. 10.1177/0269881114568039
    1. Johnson MW, & Griffiths RR (2017). Potential Therapeutic Effects of Psilocybin. Neurotherapeutics: The Journal of the American Society for Experimental Neurotherapeutics, 14(3), 734–740. 10.1007/s13311-017-0542-y
    1. Kusch M, Grau P, Warner RC, Loyo KT, Zhang X, Fritz N, & Wetterneck CT (2017). Inclusion of ethnic and racial minorities with PTSD in evidence-based clinical trials: A report card [Poster presentation]. International Society for Traumatic Stress Studies.
    1. Landrine H, Klonoff EA, Corral I, Fernandez S, & Roesch S (2006). Conceptualizing and measuring ethnic discrimination in health research. Journal of Behavioral Medicine, 29(1), 79–94. 10.1007/s10865-005-9029-0
    1. Lane RD, Ryan L, Nadel L, & Greenberg L (2015). Memory reconsolidation, emotional arousal, and the process of change in psychotherapy: New insights from brain science. The Behavioral and Brain Sciences, 38, e1. 10.1017/S0140525X14000041
    1. Lester K, Resick PA, Young-Xu Y, & Artz C (2010). Impact of race on early treatment termination and outcomes in posttraumatic stress disorder treatment. Journal of Consulting and Clinical Psychology, 78(4), 480–489. 10.1037/a0019551
    1. Liu WM, Liu RZ, Garrison YL, Kim JYC, Chan L, Ho Y, & Yeung CW (2019). Racial trauma, microaggressions, and becoming racially innocuous: The role of acculturation and White supremacist ideology. The American Psychologist, 74(1), 143–155. 10.1037/amp0000368
    1. Lovibond SH, & Lovibond PF (1995). Manual for the depression anxiety & stress scales (2nd Ed.). Psychology Foundation.
    1. MacLean KA, Johnson MW, & Griffiths RR (2011). Mystical experiences occasioned by the hallucinogen psilocybin lead to increases in the personality domain of openness. Journal of Psychopharmacology, 25(11), 1453–1461. 10.1177/0269881111420188
    1. Michaels TI, Purdon J, Collins A, & Williams MT (2018). Inclusion of people of color in psychedelic-assisted psychotherapy: A review of the literature. BMC Psychiatry, 18(1), 245. 10.1186/s12888-018-1824-6
    1. Mithoefer MC, Mithoefer AT, Feduccia AA, Jerome A, Wagner M, Wymer J, Holland J, Hamilton S, Yazar-Klosinski B, Emerson A, & Doblin R (2018). 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder in military veterans, firefighters, and police officers: A randomised, double-blind, dose-response, phase 2 clinical trial. The Lancet Psychiatry, 5(6), 486–497. 10.1016/S2215-0366(18)30135-4
    1. Moore LD, & Elkavich A (2008). Who’s using and who’s doing time: Incarceration, the war on drugs, and public health. American Journal of Public Health, 98(9 Suppl), S176–S180. 10.2105/ajph.98.supplement_1.s176
    1. Norton PJ (2007). Depression Anxiety and Stress Scales (DASS-21): Psychometric analysis across four racial groups. Anxiety, Stress, and Coping, 20(3), 253–265. 10.1080/10615800701309279
    1. O’Keefe VM, Wingate LR, Cole AB, Hollingsworth DW, & Tucker RP (2015). Seemingly harmless racial communications are not so harmless: Racial microaggressions lead to suicidal ideation by way of depression symptoms. Suicide & Life-Threatening Behavior, 45(5), 567–576. 10.1111/sltb.12150
    1. Ot’alora GM, Grigsby J, Poulter B, Van Derveer JW, Giron SG, Jerome L, Feduccia AA, Hamilton S, Yazar-Klosinski B, Emerson A, Mithoefer MC, & Doblin R (2018). 3,4-Methylenedioxymethamphetamine-assisted psychotherapy for treatment of chronic posttraumatic stress disorder: A randomized phase 2 controlled trial. Journal of Psychopharmacology, 32(12), 1295–1307. 10.1177/0269881118806297
    1. Pascoe EA, & Smart Richman L (2009). Perceived discrimination and health: A meta-analytic review. Psychological Bulletin, 135(4), 531–554. 10.1037/a0016059
    1. Peer E, Brandimarte L, Samat S, & Acquisti A (2017). Beyond the Turk: Alternative platforms for crowdsourcing behavioral research. Journal of Experimental Social Psychology, 70, 153–163. 10.1016/j.jesp.2017.01.006
    1. Pierce C (1970). Offensive mechanisms. In Barbour F (Ed.), The Black seventies (pp. 265–282). Porter Sargent.
    1. Powers MB, Halpern JM, Ferenschak MP, Gillihan SJ, & Foa EB (2010). A meta-analytic review of prolonged exposure for posttraumatic stress disorder. Clinical Psychology Review, 30(6), 635–641. 10.1016/j.cpr.2010.04.007
    1. Priest N, Paradies Y, Trenerry B, Truong M, Karlsen S, & Kelly Y (2013). A systematic review of studies examining the relationship between reported racism and health and wellbeing for children and young people. Social Science & Medicine (1982), 95, 115–127. 10.1016/j.socscimed.2012.11.031
    1. Roseman L, Nutt DJ, & Carhart-Harris RL (2018). Quality of acute psychedelic experience predicts therapeutic efficacy of psilocybin for treatment-resistant depression. Frontiers in Pharmacology, 8, 974. 10.3389/fphar.2017.00974
    1. Ross S, Bossis A, Guss J, Agin-Liebes G, Malone T, Cohen B, Mennenga SE, Belser A, Kalliontzi K, Babb J, Su Z, Corby P, & Schmidt BL (2016). Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: A randomized controlled trial. Journal of Psychopharmacology (Oxford, England), 30(12), 1165–1180. 10.1177/0269881116675512
    1. Sanches RF, de Lima Osório F, Dos Santos RG, Macedo LRH, Maia-de-Oliveira JP, Wichert-Ana L, de Araujo DB, Riba J, Crippa JAS, & Hallak JEC (2016). Antidepressant effects of a single dose of ayahuasca in patients with recurrent depression: A SPECT study. Journal of Clinical Psychopharmacology, 36(1), 77–81. 10.1097/JCP.0000000000000436
    1. Schottenbauer MA, Glass CR, Arnkoff DB, Tendick V, & Gray SH (2008). Nonresponse and dropout rates in outcome studies on PTSD: Review and methodological considerations. Psychiatry, 71(2), 134–168. 10.1521/psyc.2008.71.2.134
    1. Shalit N, Rehm J, & Lev-Ran S (2019). Epidemiology of hallucinogen use in the U.S. results from the national epidemiologic survey on alcohol and related conditions III. Addictive Behaviors, 89, 35–43. 10.1016/j.addbeh.2018.09.020
    1. Sherry A, & Henson RK (2005). Conducting and interpreting canonical correlation analysis in personality research: A user-friendly primer. Journal of Personality Assessment, 84(1), 37–48. 10.1207/s15327752jpa8401_09
    1. Simons RL, Simons LG, Burt CH, Drummund H, Stewart E, Brody GH, Gibbons FX, & Cutrona C (2006). Supportive parenting moderates the effect of discrimination upon anger, hostile view of relationships, and violence among African American boys. Journal of Health and Social Behavior, 47(4), 373–389. 10.1177/002214650604700405
    1. Soto JA, Dawson-Andoh NA, & BeLue R (2011). The relationship between perceived discrimination and Generalized Anxiety Disorder among African Americans, Afro Caribbeans, and non-Hispanic Whites. Journal of Anxiety Disorders, 25(2), 258–265. 10.1016/j.janxdis.2010.09.011
    1. Sue DW, Capodilupo CM, Torino GC, Bucceri JM, Holder AMB, Nadal KL, & Esquilin M (2007). Racial microaggressions in everyday life: Implications for clinical practice. The American Psychologist, 62(4), 271–286. 10.1037/0003-066X.62.4.271
    1. Tabachnick BG, & Fidell LS (2007). Using multivariate statistics (5th Ed.). Allyn & Bacon/Pearson Education.
    1. Terwilliger BG, Bach N, Bryan C, & Williams WT (2013). Multicultural versus colorblind ideology: Implications for mental health and counseling. Nova Science Publishers.
    1. Williams MT (2020a). Microaggressions: Clarification, evidence, and impact. Perspectives on Psychological Science: A Journal of the Association for Psychological Science, 15(1), 3–26. 10.1177/1745691619827499
    1. Williams MT (2020b). Psychology cannot afford to ignore the many harms caused by microaggressions. Perspectives on Psychological Science: A Journal of the Association for Psychological Science, 15(1), 38–43. 10.1177/1745691619893362
    1. Williams MT, & Bonner L (2006). Sex education attitudes and outcomes among North American women. Adolescence, 41(161), 1–14.
    1. Williams MT, Malcoun E, Sawyer BA, Davis DM, Nouri LB, & Bruce SL (2014). Cultural adaptations of prolonged exposure therapy for treatment and prevention of posttraumatic stress disorder in African Americans. Behavioral Sciences (Basel, Switzerland), 4(2), 102–124. 10.3390/bs4020102
    1. Williams MT, Metzger IW, Leins C, & DeLapp C (2018). Assessing racial trauma within a DSM–5 framework: The UConn racial/ethnic stress & trauma survey. Practice Innovations, 3(4), 242–260. 10.1037/pri0000076
    1. Williams MT, Printz D, Ching T, & Wetterneck CT (2018). Assessing PTSD in ethnic and racial minorities: Trauma and racial trauma. Directions in Psychiatry, 38(3), 179–196.
    1. Williams MT, Printz DMB, & DeLapp RCT (2018). Assessing racial trauma with the Trauma Symptoms of Discrimination Scale. Psychology of Violence, 8(6), 735–747. 10.1037/vio0000212
    1. Williams MT, Reed S, & Aggarwal R (2019). Culturally-informed research design issues in a study for MDMA-assisted psychotherapy for posttraumatic stress disorder. Journal of Psychedelic Studies, 4(1), 40–50. 10.1556/2054.2019.016
    1. Williams M, Gooden AMC, & Davis D (2012). African Americans, European Americans and pathological stereotypes: An African-centered perspective. In Hayes GR, & Bryant MH (Eds.), Psychology of culture (pp. 25–46. Nova Science Publishers.
    1. Wu Z, Noh S, Kaspar V, & Schimmele CM (2003). Race, ethnicity, and depression in Canadian society. Journal of Health and Social Behavior, 44(3), 426–441. 10.2307/1519788
    1. Zoellner LA, Feeny NC, Fitzgibbons LA, & Foa EB (1999). Response of African American and Caucasian women to cognitive behavioral therapy for PTSD. Behavior Therapy, 30(4), 581–595. 10.1016/S0005-7894(99)80026-4

Source: PubMed

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

3
Abonneren